GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Equity-to-Asset

Qilian International Holding Group (Qilian International Holding Group) Equity-to-Asset : 0.84 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Qilian International Holding Group's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $42.79 Mil. Qilian International Holding Group's Total Assets for the quarter that ended in Sep. 2023 was $51.26 Mil. Therefore, Qilian International Holding Group's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.84.

The historical rank and industry rank for Qilian International Holding Group's Equity-to-Asset or its related term are showing as below:

QLI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34   Med: 0.56   Max: 0.84
Current: 0.84

During the past 7 years, the highest Equity to Asset Ratio of Qilian International Holding Group was 0.84. The lowest was 0.34. And the median was 0.56.

QLI's Equity-to-Asset is ranked better than
87.21% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs QLI: 0.84

Qilian International Holding Group Equity-to-Asset Historical Data

The historical data trend for Qilian International Holding Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Equity-to-Asset Chart

Qilian International Holding Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Equity-to-Asset
Get a 7-Day Free Trial 0.56 0.54 0.73 0.82 0.84

Qilian International Holding Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.69 0.82 0.82 0.84

Competitive Comparison of Qilian International Holding Group's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qilian International Holding Group's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's Equity-to-Asset falls into.



Qilian International Holding Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Qilian International Holding Group's Equity to Asset Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Equity to Asset (A: Sep. 2023 )=Total Stockholders Equity/Total Assets
=42.792/51.258
=0.83

Qilian International Holding Group's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=42.792/51.258
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qilian International Holding Group  (NAS:QLI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Qilian International Holding Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Qilian International Holding Group (Qilian International Holding Group) Business Description

Traded in Other Exchanges
N/A
Address
Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Qilian International Holding Group (Qilian International Holding Group) Headlines

From GuruFocus